Is India geared up for regular screening of CHDs in kids?
/
DateSep 25 2021
HD Medical has developed the HD Steth, cleared by the US FDA, that addresses this problem. Read More →
Cohort Company News
Is India geared up for regular screening of CHDs in kids? (featuring HD Medical)
/
DateSep 25 2021
HD Medical has developed the HD Steth, cleared by the US FDA, that addresses this problem. Chennai: Congenital Heart Defects (CHDs) are among the most... Read More →
21 start-ups selected to innovate for healthy ageing, feat. SepTec
/
DateSep 22 2021
The awards are part of the Healthy Longevity Global Competition – a multiyear, multimillion-dollar international competition seeking breakthrough innovations to extend human health and function later in life. Read More →
Xealth Secures $24 Million in Series B Funding to Accelerate Digital Health
/
DateSep 21 2021
Xealth, the leader in enabling digital health at scale, today announced that the company has secured $24 million in Series B funding led by Advocate Aurora Enterprises, a subsidiary of Advocate Aurora Health. Read More →
Co-founder of Avisi Technologies named one of the Greater Philadelphia’s Inno Under 25
/
DateSep 21 2021
Along with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate, a nanotechnology-enabled ocular implant to treat glaucoma. Read More →
Co-founder of Avisi Technologies named one of the Greater Philadelphia’s Inno Under 25
/
DateSep 21 2021
Applaud Medical wins FDA breakthrough device designation for urinary stone deviceAlong with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate,... Read More →
Naluri: The Digital Health Tech Company Of The Future
/
DateSep 21 2021
Digital health tech company Naluri gives you remote digital health monitoring and expert advice in the palm of your hands. When it comes to the... Read More →
Bluegrass Vascular Announces Decision by Medicare to Assign a New Technology Ambulatory Payment Classification (APC) for the Surfacer® System Procedure
/
DateSep 20 2021
The new code is C9780, Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance. Read More →
Rhaeos, Inc. Awarded $4 Million NIH SBIR Grant to Expand Quantitative Measurement Capabilities of its FlowSense™ Noninvasive Wireless Sensor
/
DateSep 16 2021
Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program through the National Institute of Neurological Disorders and Stroke (NINDS). Read More →
FDA Clears Fully Automated Cardiac Ultrasound Solution to Measure 2D and Doppler
/
DateSep 14 2021
Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated decision support tool for echocardiography. Read More →
Vertigo Treatment Receives FDA Breakthrough Device Designation, featuring Otolith Labs
/
DateSep 13 2021
Otolith Labs, launched at the Halcyon Incubator, has received U.S. Food and Drug Administration (FDA) Breakthrough Device designation for its medical device that is designed to be prescribed by physicians for the treatment of vertigo. Read More →
Automated lung sound analysis using the LungPass platform: a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19
/
DateSep 09 2021
Lower respiratory tract (LRT) involvement, observed in about 20% of patients suffering from coronavirus disease 2019 (COVID-19), is associated with a more severe clinical course, adverse outcomes, and long-term sequelae [1, 2]. Read More →
Madorra wins FDA breakthrough nod for home vulvovaginal atrophy treatment device
/
DateSep 09 2021
Madorra this week said it has received FDA breakthrough device designation for its noninvasive, home-use device for moderate to severe vulvovaginal atrophy. Read More →
Nutromics won in the category of ‘Technology Platform Solution of the Year’ at the AIIA’s 2021 national iAwards!
/
DateSep 09 2021
We are excited to announce that last night Nutromics won in the category of 'Technology Platform Solution of the Year' at the AIIA's 2021 national iAwards! Read More →
InBrace Raises $102M Series D Financing
/
DateSep 08 2021
InBrace, the orthodontic company behind the novel Smartwire™ category of behind-the-teeth, teeth straightening, today announced the closing of an oversubscribed $102 million Series D financing by funds affiliated with new investor groups co-led by Farallon Capital Management, L.L.C. and Marshall Wace. Read More →
Stryker Acquires Med Device Company Gauss Surgical
/
DateSep 07 2021
Stryker today announced the acquisition of Gauss Surgical, a Menlo Park, CA-based medical device company that has developed Triton™, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Read More →
Sentien Biotechnologies Partners with BARDA to Evaluate High Dose Cohort in Phase 1/2 Trial of SBI-101 for Treatment of Acute Kidney Injury Associated with Sepsis
/
DateSep 02 2021
Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA). Read More →
Onkos Surgical raises $15M Series C
/
DateSep 01 2021
Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopedic procedures based in Parsippany, announced Wednesday that it has raised $15 million in Series C funding from its existing investor syndicate. Read More →
Australian medtech startup Nutromics bags $4M in pre-market funding for continuous molecular monitoring device
/
DateAug 27 2021
Nutromics, an Australian medical technology startup, has raised A$5.7 million ($4.1 million) in a pre-market funding round participated by private investors. This brings its total capital raised in the past three years to A$10 million ($7.2 million). Read More →
Eclipse Regenesis Awarded National Institutes of Health (NIH) Grant
/
DateAug 26 2021
Eclipse Regenesis, Inc., developer of the first restorative therapy to address pediatric and adult Short Bowel Syndrome, has been awarded a National Institutes of Health Small Business Innovation Research (NIH SBIR) Fast Track grant of $1.7 million. Read More →